Introduction
REXFARM 60 is a premium-quality pharmaceutical formulation containing Raloxifene Hydrochloride Tablets IP 60 mg, a selective estrogen receptor modulator (SERM) primarily prescribed for the prevention and treatment of osteoporosis in postmenopausal women. Osteoporosis is a progressive bone disorder characterized by decreased bone density and increased bone fragility, significantly raising the risk of fractures, particularly in the spine, hips, and wrists.
Raloxifene Hydrochloride works by mimicking the beneficial effects of estrogen on bone tissue without stimulating breast or uterine tissue in the same way as natural estrogen. It helps maintain bone mineral density, reduces bone loss, and lowers the risk of vertebral fractures. In addition to its bone-protective effects, Raloxifene has been shown to reduce the risk of invasive breast cancer in certain postmenopausal women at increased risk, as determined by their healthcare provider.
Manufactured under stringent GMP-compliant quality standards, REXFARM 60 is formulated to ensure safety, efficacy, and consistent therapeutic performance. It should always be taken under the supervision of a qualified healthcare professional and combined with adequate calcium intake, vitamin D supplementation (if recommended), regular weight-bearing exercise, and a healthy lifestyle to maximize bone health.
Uses
REXFARM 60 is commonly prescribed for:
Treatment of osteoporosis in postmenopausal women.
Prevention of osteoporosis after menopause.
Increasing and maintaining bone mineral density.
Reducing the risk of vertebral (spinal) fractures.
Lowering the risk of invasive breast cancer in eligible postmenopausal women, as advised by a healthcare professional.
Long-term management of bone health in women at high risk of osteoporosis.
Benefits
Strengthens Bones
Raloxifene helps slow bone loss after menopause, improving bone strength and reducing the progression of osteoporosis.
Reduces Fracture Risk
Regular treatment significantly lowers the risk of vertebral fractures associated with weakened bones.
Selective Estrogen Receptor Modulation
Raloxifene provides estrogen-like benefits for bones while minimizing stimulation of breast and uterine tissues.
Supports Long-Term Bone Health
Continuous treatment helps preserve bone mineral density and contributes to healthier bones over time.
May Reduce Breast Cancer Risk
In selected postmenopausal women, Raloxifene may lower the risk of developing invasive estrogen receptor-positive breast cancer when prescribed appropriately.
Convenient Once-Daily Therapy
The once-daily oral tablet promotes better treatment adherence and simplifies long-term osteoporosis management.
Improves Quality of Life
By reducing fracture risk and maintaining mobility, REXFARM 60 helps postmenopausal women remain active and independent.
Dosage
Take REXFARM 60 exactly as prescribed by your healthcare provider.
General dosage recommendations include:
Swallow one tablet whole with water.
It may be taken with or without food.
Take the medicine at the same time every day.
Continue therapy for the full duration recommended by your doctor.
Ensure adequate calcium and vitamin D intake if advised by your physician.
The dosage may vary depending on:
Bone health status
Individual fracture risk
Medical history
Other medications
Response to treatment
Do not discontinue treatment without consulting your healthcare provider, as long-term therapy is often necessary for optimal bone protection.
Side Effects
Like all medicines, REXFARM 60 may cause side effects, although many patients tolerate it well.
Common side effects include:
Hot flashes
Leg cramps
Muscle pain
Joint pain
Swelling of hands, feet, or ankles
Mild headache
Flu-like symptoms
Increased sweating
Less common but serious side effects may include:
Deep vein thrombosis (blood clots in the legs)
Pulmonary embolism (blood clots in the lungs)
Stroke in high-risk individuals
Severe allergic reactions
Vision disturbances
Seek immediate medical attention if you experience sudden chest pain, difficulty breathing, swelling or pain in one leg, sudden weakness, or changes in vision.
Precautions and Warnings
Before taking REXFARM 60, inform your healthcare provider if you have:
History of blood clots
Stroke or transient ischemic attack (TIA)
Heart disease
Liver disease
Kidney disease
High cholesterol
Prolonged immobilization
Pregnancy or breastfeeding (Raloxifene is contraindicated)
Important precautions include:
Use only under medical supervision.
Not intended for use in premenopausal women.
Avoid prolonged immobility during treatment, as it may increase the risk of blood clots.
Inform your doctor before surgery or long-distance travel.
Maintain regular physical activity and weight-bearing exercise.
Consume sufficient calcium and vitamin D as advised.
Attend regular bone density evaluations and follow-up appointments.
Store below 25°C in a cool, dry place away from direct sunlight and moisture.
Keep out of reach of children.
Conclusion
REXFARM 60 Raloxifene Hydrochloride Tablets IP 60 mg is an effective treatment option for the prevention and management of osteoporosis in postmenopausal women. As a selective estrogen receptor modulator, it helps preserve bone mineral density, strengthens bones, and significantly reduces the risk of vertebral fractures while offering the additional benefit of lowering the risk of invasive breast cancer in selected patients.
Its once-daily dosing and well-established clinical efficacy make REXFARM 60 a valuable part of long-term bone health management. When combined with adequate calcium and vitamin D intake, regular exercise, and routine medical monitoring, REXFARM 60 helps support stronger bones, improved mobility, and a better quality of life for postmenopausal women.
Product Information
1. What is REXFARM 60 used for?
REXFARM 60 is used for the treatment and prevention of osteoporosis in postmenopausal women and, in selected patients, to reduce the risk of invasive breast cancer.
2. What are Raloxifene Hydrochloride Tablets IP 60 mg used for?
Raloxifene Tablets are prescribed to improve bone strength, maintain bone mineral density, reduce vertebral fracture risk, and support long-term bone health after menopause.
3. How does REXFARM 60 work?
Raloxifene acts as a selective estrogen receptor modulator (SERM), producing estrogen-like effects on bone tissue to reduce bone loss while limiting estrogen activity in breast and uterine tissues.
4. Can REXFARM 60 increase bone density?
Yes. Regular treatment helps maintain and improve bone mineral density, reducing the progression of osteoporosis.
5. Can REXFARM 60 prevent fractures?
Yes. It has been shown to significantly reduce the risk of vertebral fractures in postmenopausal women with osteoporosis.
6. Is REXFARM 60 a hormone replacement therapy?
No. REXFARM 60 is not hormone replacement therapy (HRT). It belongs to the class of selective estrogen receptor modulators (SERMs).
7. What are the common side effects of REXFARM 60?
Common side effects include hot flashes, leg cramps, joint pain, muscle pain, headache, swelling of the legs or feet, and flu-like symptoms.
8. Can REXFARM 60 reduce breast cancer risk?
Yes. In certain postmenopausal women at increased risk, Raloxifene may reduce the risk of invasive estrogen receptor-positive breast cancer when prescribed by a healthcare professional.
9. Who should not take REXFARM 60?
Women with a history of blood clots, active venous thromboembolism, pregnancy, or severe liver disease should avoid REXFARM 60 unless specifically advised otherwise by a specialist.
10. How can I get the best results from REXFARM 60?
Take the medicine regularly as prescribed, maintain adequate calcium and vitamin D intake, perform weight-bearing exercises, avoid smoking, limit alcohol consumption, and attend regular bone density assessments to support optimal bone health.
